Search

Oleg Selyutin Phones & Addresses

  • 14133 Marie Ct, Princeton Jct, NJ 08550
  • Princeton Junction, NJ
  • 1245 Avenue X, Brooklyn, NY 11235 (718) 646-1149 (718) 648-5057
  • 1245 Avenue X APT P2, Brooklyn, NY 11235

Work

Company: Merck Position: Senior specialist

Resumes

Resumes

Oleg Selyutin Photo 1

Senior Specialist

View page
Location:
Princeton Junction, NJ
Work:
Merck
Senior Specialist

Publications

Us Patents

Fused Tricyclic Silyl Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases

View page
US Patent:
8609635, Dec 17, 2013
Filed:
Mar 4, 2011
Appl. No.:
13/041082
Inventors:
Anilkumar Gopinadhan Nair - Edison NJ, US
Kartik M. Keertikar - East Windsor NJ, US
Seong Heon Kim - Livingston NJ, US
Joseph A. Kozlowski - Princeton NJ, US
Stuart Rosenblum - West Orange NJ, US
Oleg B. Selyutin - West Windsor NJ, US
Michael Wong - Somerset NJ, US
Wensheng Yu - Edison NJ, US
Qingbei Zeng - Edison NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/695
C07F 7/10
US Classification:
514 63, 544 60, 544 69, 546 14, 548110
Abstract:
The present invention relates to novel Fused Tricyclic Silyl Compounds of Formula (I):.

2,3-Substituted Indole Derivatives For Treating Viral Infections

View page
US Patent:
20110033417, Feb 10, 2011
Filed:
Aug 27, 2008
Appl. No.:
12/675897
Inventors:
Gopinadhan N. Anilkumar - Edison NJ, US
Frank Bennett - Cranford NJ, US
Tin-Yau Chan - Edison NJ, US
Kevin X. Chen - Edison NJ, US
Mousumi Sannigrahi - Summit NJ, US
Francisco Velazquez - Clinton NJ, US
Srikanth Venkatraman - Edison NJ, US
Qingbei Zeng - Edison NJ, US
Jose S. Duca - Cranford NJ, US
Charles A. Lesburg - Short Hills NJ, US
Joseph A. Kozlowski - Princeton NJ, US
F. George Njoroge - Warren NJ, US
Stuart B. Rosenblum - West Orange NJ, US
Neng-Yang Shih - Lexington MA, US
Stephen J. Gavalas - Manhasset NJ, US
Yueheng Jiang - Whitehouse Station NJ, US
Patrick A. Pinto - Morris Plains NJ, US
Haiyan Pu - Livingston NJ, US
Oleg B. Selyutin - West Windsor NJ, US
Bancha Vibulbhan - Kenilworth NJ, US
Li Wang - Nanuet NY, US
Wanli Wu - East Brunswick NJ, US
Weiying Yang - Monmouth Junction NJ, US
Yuhua Huang - Westfield NJ, US
Hsueh-Cheng Huang - Scarsdale NY, US
Robert Palermo - Seattle WA, US
Boris Feld - New Milford NJ, US
International Classification:
A61K 38/21
C07D 401/04
C07D 413/14
C07D 209/42
C07D 401/14
C07D 417/14
C07D 407/14
C07D 409/14
A61K 31/4439
A61K 31/444
A61K 31/404
A61K 31/4545
A61K 31/513
A61K 31/443
A61K 31/4709
A61K 31/4436
A61K 31/5377
A61K 31/538
A61K 31/5415
A61K 31/7088
A61K 31/7052
A61K 39/12
A61K 39/42
A61P 31/12
A61P 31/14
US Classification:
424 854, 5462781, 5462691, 548492, 546256, 546194, 544310, 5462721, 5462697, 5462684, 5462687, 546167, 5462761, 5462754, 544131, 5462711, 544105, 5462701, 544 12, 514339, 514333, 514419, 514340, 514318, 514274, 514342, 514341, 514338, 514314, 5142352, 5142305, 5142232, 5142235, 514 44 A, 514 43, 4242041, 4241471, 4241591
Abstract:
The present invention relates to 2,3-Substituted Indole Derivatives, compositions comprising at least one 2,3-Substituted Indole Derivative, and methods of using the 2,3-Substituted Indole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.

Tricyclic Indole Derivatives And Methods Of Use Thereof

View page
US Patent:
20110189127, Aug 4, 2011
Filed:
Jun 10, 2009
Appl. No.:
12/997654
Inventors:
Srikanth Venkatraman - Edison NJ, US
Anilkumar Gopinadhan Nair - Edison NJ, US
Kevin X. Chen - Edison NJ, US
Francisco Valazquez - Clinton NJ, US
Qingbei Zeng - Edison NJ, US
Duan Liu - Arlington MA, US
Yueheng Jiang - Whitehouse Station NJ, US
Joseph A. Kozlowski - Princeton NJ, US
F. George Njoroge - Warren NJ, US
Stuart B. Rosenblum - West Orange NJ, US
Stephen J. Gavalas - Manhasset NY, US
Patrick A. Pinto - Morris Plains NJ, US
Oleg B. Selyutin - West Windsor NJ, US
Bancha Vibulbhan - Kenilworth NJ, US
International Classification:
A61K 31/4439
C07D 401/14
C07D 491/22
A61K 31/437
A61K 31/517
A61K 31/47
A61K 38/21
A61K 31/7052
A61K 39/00
A61K 39/395
A61K 31/7056
A61P 31/12
US Classification:
424 854, 5462767, 514338, 546 48, 514280, 544284, 51426621, 546174, 514314, 514 44 A, 4241841, 4241301, 4241411, 514 43
Abstract:
The present invention relates to Tricyclic Indole Derivatives, compositions comprising at least one Tricyclic Indole Derivatives, and methods of using the Tricyclic Indole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.

3-(1H-Pyrazol-4-Yl)Pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor

View page
US Patent:
20210395224, Dec 23, 2021
Filed:
Oct 24, 2019
Appl. No.:
17/286591
Inventors:
- Rahway NJ, US
- Shanghai, CN
Xiaolei Gao - Bridgewater NJ, US
Scott T. Harrison - Elkins Park PA, US
Timothy J. Henderson - Natick MA, US
Michael Man-Chu Lo - Bedminster NJ, US
Zhaoyang Meng - Ambler PA, US
James Mulhearn - Elkins Park PA, US
Vanessa L. Rada - Hatfield PA, US
Jeffrey W. Schubert - North Wales PA, US
Oleg B. Selyutin - West Windsor NJ, US
David M. Tellers - Lansdale PA, US
Ling Tong - Warren NJ, US
Fengqi Zhang - Edison NJ, US
Jianming Bao - South San Francisco CA, US
Chunsing Li - Shanghai, CN
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
MSD R&D (China) Co. LTD. - Shanghai
International Classification:
C07D 401/14
C07D 405/14
Abstract:
The present invention is directed to cinnolinyl and quinolinyl pyrazol-4-yl-pyridine compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

3-(1H-Pyrazol-4-Yl)Pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor

View page
US Patent:
20210380580, Dec 9, 2021
Filed:
Jun 22, 2018
Appl. No.:
16/621953
Inventors:
- Rahway NJ, US
- SHANGHAI, CN
Qiaolin DENG - Princeton NJ, US
Melissa EGBERTSON - Ambler PA, US
Ronald FERGUSON, II - Scotch Plains NJ, US
Xiaolei GAO - Bridgewater NJ, US
Scott Timothy HARRISON - Elkins Park PA, US
Timothy J. HENDERSON - Natick MA, US
Sandra L. KNOWLES - Princeton NJ, US
Chunsing LI - Shanghai, CN
Michael Man-Chu LO - Bedminster NJ, US
Meng NA - Shanghai, CN
Michael T. RUDD - Collegeville PA, US
Oleg B. Selyutin - West Windsor NJ, US
David M. TELLERS - Lansdale PA, US
Ling TONG - Warren NJ, US
Fengqi ZHANG - Edison NJ, US
Takao SUZUKI - Shanghai, CN
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
MSD R&D (CHINA) CO., LTD. - SHANGHAI
International Classification:
C07D 471/04
C07D 401/14
C07D 417/14
C07D 413/14
C07D 487/04
C07D 405/14
Abstract:
The present invention is directed to pyrazol-4-yl-pyridine compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

3-(1H-Pyrazol-4-Yl)Pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor

View page
US Patent:
20200207758, Jul 2, 2020
Filed:
Jun 22, 2018
Appl. No.:
16/621959
Inventors:
Jianming BAO - San Mateo CA, US
Qiaolin DENG - Princeton NJ, US
Melissa EGBERTSON - Ambler PA, US
Ronald FERGUSON, II - Scotch Plains NJ, US
Xiaolei GAO - Bridgewater NJ, US
Scott Timothy HARRISON - Elkins Park PA, US
Sandra L. KNOWLES - Princeton NJ, US
Chunsing LI - Shanghai, CN
Michael Man-Chu LO - Bedminster NJ, US
Zhaoyang MENG - Ambler PA, US
Meng NA - Shanghai, CN
Michael T. RUDD - Collegeville PA, US
Oleg SELYUTIN - West Windsor NJ, US
David M. TELLERS - Lansdale PA, US
Ling TONG - Warren NJ, US
Fengqi ZHANG - Edison NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 471/04
C07D 401/14
C07D 401/04
C07D 413/14
C07D 405/14
C07D 491/048
C07D 498/04
Abstract:
The present invention is directed to pyrazol-4-yl-pyridine compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

3-(1H-Pyrazol-4-Yl)Pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor

View page
US Patent:
20200069671, Mar 5, 2020
Filed:
Nov 5, 2019
Appl. No.:
16/674546
Inventors:
- Rahway NJ, US
Jianming Bao - South San Francisco CA, US
Melissa Egbertson - Ambler PA, US
Xiaolei Gao - Bridgewater NJ, US
Scott T. Harrison - Elkins Park PA, US
Sandra L. Knowles - Princeton NJ, US
Chunsing Li - Shanghai, CN
Michael Man-Chu Lo - Bedminster NJ, US
Zhaoyang Meng - Ambler PA, US
Michael T. Rudd - Collegeville PA, US
Oleg B. Selyutin - West Windsor NJ, US
David M. Tellers - Lansdale PA, US
Ling Tong - Warren NJ, US
Jenny Miu-Chun Wai - Harleysville PA, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
MSD R & D (China) Co., Ltd. - Shanghai
International Classification:
A61K 31/4439
A61P 25/28
A61P 25/18
A61P 25/16
A61K 31/437
C07D 401/14
C07D 405/14
C07D 471/04
Abstract:
The present invention is directed to pyrazol-4-yl-pyridine compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

3-(1H-Pyrazol-4-Yl)Pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor

View page
US Patent:
20190000824, Jan 3, 2019
Filed:
Dec 19, 2016
Appl. No.:
16/062500
Inventors:
- Rahway NJ, US
Jianming Bao - South San Francisco CA, US
Melissa Egbertson - Ambler PA, US
Xiaolei Gao - Bridgewater NJ, US
Scott T. Harrison - Elkins Park PA, US
Sandra L. Knowles - Princeton NJ, US
Chunsing Li - Shanghai, CN
Michael Man-Chu Lo - Bedminster NJ, US
Zhaoyang Meng - Ambler PA, US
Michael T. Rudd - Collegeville PA, US
Oleg B. Selyutin - West Windsor NJ, US
David M. Tellers - Lansdale PA, US
Ling Tong - Warren NJ, US
Jenny Miu-Chun Wai - Harleysville PA, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/4439
A61K 31/437
A61P 25/16
A61P 25/18
A61P 25/28
Abstract:
The present invention is directed to pyrazol-4-yl-pyridine compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine 5 receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.
Oleg B Selyutin from Princeton Junction, NJ, age ~52 Get Report